跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
BRAFTOVI encorafenib 75 mg capsule blister pack
Approved
STANDARD
BRAFTOVI encorafenib 75 mg capsule blister pack
Pierre Fabre Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
7f737805873f3b21
Company
Pierre Fabre Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
7f737805873f3b21
Product Name
BRAFTOVI encorafenib 75 mg capsule blister pack
Artg Id
295441
Artg Name
BRAFTOVI encorafenib 75 mg capsule blister pack
Sponsor
Pierre Fabre Australia Pty Ltd
Company Detail Path
/organization/pierre-fabre-australia-pty-ltd
Artg Date
2019-01-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b59a5c9c62a0f1975ba4c15c3dd3eba5.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/2ed463c145d8f379effd81e8f92a2b28.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
7f737805873f3b21
Type
Standard
Back to TGA Approvals
BRAFTOVI encorafenib 75 mg capsule blister pack - TGA Drug Approval Details